IL-17A antagonist biosimilar-induced ulcerative colitis in a patient with ankylosing spondylitis

IL-17A antagonist biosimilar-induced ulcerative colitis in a patient with ankylosing spondylitis

Saved in:

Bibliographic Details
Main Authors:	Haihong Wang, Zhenhua Wen, Li Deng
Format:	Article
Language:	English
Published:	Termedia Publishing House 2025-02-01
Series:	Archives of Medical Science
Online Access:	https://www.archivesofmedicalscience.com/IL-17A-antagonist-biosimilar-induced-ulcerative-colitis-in-a-patient-with-ankylosing,200477,0,2.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Challenging Case of Severe Ulcerative Colitis following the Initiation of Secukinumab for Ankylosing Spondylitis
by: Dean Ehrlich, et al.
Published: (2018-01-01)

ILIOCAVAL THROMBOSIS WITH A PROXIMAL BORDER TO THE SUPRARENAL SEGMENT OF THE INFERIOR VENA CAVA IN A FEMALE PATIENT WITH ANKYLOSING SPONDYLITIS AND ULCERATIVE COLITIS
by: D. G. Rumyantseva, et al.
Published: (2020-06-01)

Ankylosing Spondylitis
by: Nazanin Ebrahimiadib, et al.
Published: (2021-07-01)

Retention rate of TNF inhibitors versus IL-17 inhibitors in ankylosing spondylitis patients with prior biologics experience
by: Jiwon Yang, et al.
Published: (2025-07-01)

INTERLEUKIN-17A IS A NEW TARGET OF ANTICYTOKINE THERAPY FOR ANKYLOSING SPONDYLITIS
by: Sh. F. Erdes
Published: (2016-09-01)

Comparative pharmacoeconomic effectiveness of interleukin-17 inhibitors for the treatment of ankylosing spondylitis
by: T. V. Dubinina, et al.
Published: (2022-12-01)

Ankylosing spondylitis and kinesiophobia
by: Ugur Ertem
Published: (2025-02-01)

The effectiveness of switching from an originator biological agent to its biosimilar, or vice versa, for ankylosing spondylitis in real clinical practice
by: K. V. Sakharova, et al.
Published: (2020-11-01)

Course of uveitis in patients with ankylosing spondylitis during the interleukin 17 inhibitors therapy
by: A. A. Godzenko, et al.
Published: (2023-10-01)

The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis
by: Yu. V. Muravyev, et al.
Published: (2020-05-01)

LABORATORY BIOMARKERS FOR ANKYLOSING SPONDYLITIS
by: E. N. Aleksandrova, et al.
Published: (2017-03-01)

Ankylosing spondylitis-axial spondyloarthritis
by: Aanand Narayan Malaviya
Published: (2017-01-01)

Symptomatic therapy for ankylosing spondylitis
by: Vladimir Vasilyevich Badokin
Published: (2012-03-01)

Heart damage in ankylosing spondylitis
by: A A Godzenko, et al.
Published: (2009-08-01)

OSTEOPOROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Elena Efimovna Gubar, et al.
Published: (2013-12-01)

Early diagnosis of ankylosing spondylitis
by: Sh F Erdes, et al.
Published: (2013-11-01)

OSTEOPOROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: TATIANA A. Raskina, et al.
Published: (2019-03-01)

ANKYLOSING SPONDYLITIS IN THE VOLGA BULGARIA
by: D. I. Abdulganieva, et al.
Published: (2015-09-01)

EXPERIENCE WITH RITUXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Mikhail Sergeyevich Protopopov, et al.
Published: (2013-02-01)

MUSCLE RELAXANTS: ARE THEY NEEDED IN ANKYLOSING SPONDYLITIS?
by: T. V. Dubinina, et al.
Published: (2016-09-01)

Kidney damage in patients with ankylosing spondylitis
by: G. I. Scherbakov
Published: (2021-06-01)

Spondylodiscitis in ankylosing spondylitis: Andersson lesion
by: B N Shiva Prasad, et al.
Published: (2020-01-01)

Early diagnosis of coxitis in ankylosing spondylitis
by: Sh. F. Erdes, et al.
Published: (2023-08-01)

SIGNIFICANCE OF PERIPHERAL ARTHRITIS IN ANKYLOSING SPONDYLITIS
by: Sh. F. Erdes, et al.
Published: (2014-06-01)

Cardiovascular disease in patients with ankylosing spondylitis
by: Andrei Petrovich Rebrov, et al.
Published: (2012-04-01)

Musculoskeletal losses in patients with ankylosing spondylitis
by: T. A. Raskina, et al.
Published: (2019-10-01)

Significance of asymptomatic hyperuricemia in ankylosing spondylitis
by: R. M. Balabanova, et al.
Published: (2021-06-01)

Coexistence of Ankylosing Spondylitis and Löfgren’s Syndrome
by: Senol Kobak, et al.
Published: (2014-01-01)

COURSE OF UVEITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: A. A. Godzenko, et al.
Published: (2016-09-01)

Treatment of ankylosing spondylitis during pregnancy
by: O. A. Krichevskaya, et al.
Published: (2021-07-01)

Bone Mineral Density in Ankylosing Spondylitis
by: Bahar Çakmak, et al.
Published: (2003-12-01)

The abilities of golimumab in the therapy of ankylosing spondylitis
by: Sh. F. Erdes
Published: (2014-09-01)

Symptom modifiers in therapy for ankylosing spondylitis
by: V. V. Badokin
Published: (2010-06-01)

Ankylosing Spondylitis: From Cells to Genes
by: José Francisco Zambrano-Zaragoza, et al.
Published: (2013-01-01)

Proteomics signatures associated with hip arthropathy in ankylosing spondylitis
by: Xianghui Wen, et al.
Published: (2025-05-01)

The association and clinical significance of hematological biomarkers in ankylosing spondylitis
by: Kamoho Alphonce Rapapa, et al.
Published: (2025-05-01)

Results of non-medical switching from original infliximab to its Russian biosimilar in patients with ulcerative colitis
by: Maria I. Timanovskaia, et al.
Published: (2025-01-01)

A case of juvenile ankylosing spondylitis and Crohn's disease
by: E Unsal, et al.
Published: (1997-04-01)

Ankylosing spondylitis and pregnancy: a current view on the problem
by: O. A. Krichevskaya, et al.
Published: (2018-09-01)

Behcet's Disease and Ankylosing Spondylitis: A Rare Association
by: Amina Mounir, et al.
Published: (2019-07-01)